JPRN-jRCT1061220010招募中2 期
Efficacy of Intravenous Immunoglobulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Miyahara Nobuaki0 个研究点目标入组 24 人开始时间: 2022年4月25日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Patients diagnosed with acute exacerbation of IPF
- •(2) Patients whose consent for participation in this study can be obtained personally or through his/her legal representative
- •(3) Patients who are 20 years old or older at the time of obtaining consent.
排除标准
- •(1) Patients considered to have acute exacerbation of interstitial pneumonia other than IPF (IIPs other than IPF, collagen vascular disease-associated ILD, etc.)
- •(2) Patients who cannot give consent for the use of blood products
- •(3) Patients who are denied the coexistence of infectious diseases and do not receive antibiotics
- •(4) Patients who have a history of acute exacerbation of IPF
- •(5) Patients judged unsuitable to participate in this clinical study by the investigator
研究者
相似试验
已完成
2 期
The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocolCOVID-19 disease.COVID-19, virus identifiedU07.1IRCT20200325046859N1Mashhad University of Medical Sciences50
进行中（未招募）
1 期
Early treatment with intravenous immunoglobulins for newly diagnosed myositis patientsEUCTR2016-004766-26-NLAcademic Medical Center20
已完成
2 期
Intravenous immunoglobulins as early treatment in newly diagnosed idiopathic inflammatory myopathies (IMMEDIATE): a pilot study.myositisNL-OMON46904Academisch Medisch Centrum20
已完成
不适用
IMMEDIATE study- idiopathic inflammatory myopathies- myositis (practical/clinical synonym)- auto-immune disease- neuromuscular diseaseNL-OMON25293Department of Neurology, Academic Medical Center Amsterdam20
进行中（未招募）
1 期
Early immunotherapy with intravenous immunoglobulin, cyclophosphamide and methylprednisolone in patients with anti-Hu-associated paraneoplastic sensory neuropathy (NESPA).paraneoplastic sensory neuropathy with anti-Hu antibodiesMedDRA version: 20.0Level: PTClassification code: 10072106Term: Paraneoplastic neurological syndrome Class: 100000004852CTIS2023-506942-22-01Assistance Publique Hopitaux De Paris21